Analyst Ratings for ANI Pharmaceuticals (ANIP)
ANIP Rating Summary
ANIP Price Target Summary
- Highest: $124.00 (Guggenheim)
- Lowest: $90.00 (Truist Securities)
- Average: $104.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$104.50 (+31.9%)
* Over Last 12-Mos
Rating Score: 7.1 / 10
Percentile Rank: 75%
Avg. $ Target:
$104.50 (+31.9%)
* Over Last 12-Mos
Rating Score: 7.1 / 10
Percentile Rank: 75%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/16/2026 | Canaccord | Gary Newman | New Coverage | Hold (N/A) |
91.00 (N/A) |
80.82 (79.20) |
-2% | Details |
| 7/10/2025 | H.C. Wainwright » Updated 8/11/2025 |
Brandon Folkes | New Coverage | Buy (N/A) |
93.00 (84.00) |
65.31 (79.20) |
21.27% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
